Hot Topics In Lung Infections An Issue Of Infectious Disease Clinics Of North America

In this issue of Infectious Disease Clinics, guest editors Rachael Lee and Helen W. Boucher bring their considerable expertise to the topic of Lung Infections. Top experts in the field provide important updates on hot topics such as Viral Pneumonias, Infectious Pulmonary Diseases, Infections in Heart and Lung Transplant Recipients, and more. Contains 12 practice-oriented topics including Opportunistic Infections Post-Lung Transplantation: Viral, Fungal, and Mycobacterial; Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis; Coronavirus Disease-2019 in the Immunocompromised Host; Novel and Rapid Diagnostics for Common Infections in the Critically Ill Patient; and more. Provides in-depth clinical reviews on lung infections, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

In this issue of Infectious Disease Clinics, guest editors Rachael Lee and Helen W. Boucher bring their considerable expertise to the topic of Lung Infections. Top experts in the field provide important updates on hot topics such as Viral Pneumonias, Infectious Pulmonary Diseases, Infections in Heart and Lung Transplant Recipients, and more. Contains 12 practice-oriented topics including Opportunistic Infections Post-Lung Transplantation: Viral, Fungal, and Mycobacterial; Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis; Coronavirus Disease-2019 in the Immunocompromised Host; Novel and Rapid Diagnostics for Common Infections in the Critically Ill Patient; and more. Provides in-depth clinical reviews on lung infections, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Respiratory infections are among the most common causes of morbidity and mortality worldwide. These infections present a special challenge to physicians for several reasons, including of the recent disasters caused by severe acute respiratory syndrome (SARS) and bird and swine influenza, the increase in viral and bacterial resistance to currently available anti-microbial drugs, the increased frequency of new viral lung infections in clinical practice, and the worldwide emergence of deadly drug-resistant forms of TB. For these reasons, it is important for infectious disease specialists to have an overview of emerging respiratory infections.

"Respiratory infections are one of the most common causes of morbidity and mortality worldwide. As we enter the twenty-first century, several landmark events are unfolding in the area of respiratory infections. Some of these, by assuming the form of formidable disasters, have abruptly claimed lives and led to economic loss. Examples include severe acute respiratory syndrome (SARS) and bird and swine influenza. Viral and bacterial resistance to currently available antimicrobial drugs is thwarting efforts in the management of influenza and pulmonary sepsis. Newer and emerging viral lung infections are seen more frequently in clinical practice, including post-transplant viral infections other than cytomegalovirus and Epstein-Barr virus. The frequency and diversity of serious fungal infections are increasing. Persons who are severely immunocompromised are particularly vulnerable to infection from unusual molds and yeasts that are often found naturally in the environment. Other respiratory infections pose continuous health care challenges. Examples include the changing demography of tuberculosis (TB) and emerging deadly drug-resistant forms of TB worldwide. Pediatric TB and elderly TB are on the rise and the problem of coinfection with HIV is proving difficult to diagnose and manage. Anti-tumor necrosis factor (TNF)-a therapy for autoimmune conditions results in reactivation of TB. In addition, occupational lung diseases due to airborne microbes constitute another problematic issue. Protozoal and helminthic lung infestations continue to be important clinical problems in many parts of the world. This issue of Infectious Diseases Clinics of North America is aimed at giving an up-todate and comprehensive overview of emerging respiratory infections in the twenty-first century through 14 articles written by authoritative experts from all around the globe." - p. xiii.

Pneumonia is the leading cause of death due to infectious disease. This issue of Infectious Disease Clinics, guest edited by Tom File, focuses on the controversies and questions surrounding community-acquired pneumonia, including the potential benefits of identifying biomarkers for management of CAP (which could someday become a part of routine diagnostic testing for CAP), the best therapies for influenza/viral causes of pneumonia (the most common form of the disease in children), and clinical scoring tools to help predict long term outcomes. The issue also discusses how to approach MRSA as a cause of CAP and how to approach the non-responding patient.

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.

In collaboration with Consulting Editor, Dr. Steve Krau, Dr. Randolph F. R. Rasch has put together a state-of the-art issue of the Nursing Clinics of North America devoted to Infectious Diseases. Clinical review articles from expert authors are specifically devoted to the following topics: Ebola; HIV/AIDS; Lymphatic Filariasis; Tuberculosis; STDs; Influenza (seasonal); Malaria; Lyme Disease; Hepatitis (Hep. C & Hep. B); Zika virus, particularly related to pregnancy; Oral Infections; Rat Lung Disease; and Emerging infections. Readers will come away with the latest information they need to improve outcomes in patients with infectious diseases.

In consultation with Consulting Editor, Dr. Helen Boucher, Dr. Mossad has created an issue that provides a very current look at the prevention of infections in the solid organ transplant patient. Top authors in the field have contributed clinical reviews on the following topics: Is this organ donor safe; Immunization of solid organ transplant candidates & recipients; Safe living following solid organ transplantation; Strategies for Antimicrobial Stewardship in solid organ transplant recipients; Multi drug resistant bacterial infections in solid organ transplant candidates and recipients; Yeast infections in solid organ transplant recipients; Mold infections in solid organ transplant recipients; Endemic mycoses in solid organ transplant recipients; Prevention and treatment of cytomegalovirus infections in solid organ transplant recipients; Management of BK polyomavirus infection in kidney & pancreas transplant recipients; Prevention and treatment of clostridium difficile-associated diarrhea in solid organ transplant recipients; Management of viral hepatitis in solid organ transplant recipients; Prevention and management of tuberculosis in solid organ transplant recipients; Management of mycobacteria other than tuberculosis in solid organ transplant recipients; Management of strongyloidiasis in solid organ transplant recipients; and Transplantation in HIV infected patients. Readers will come away with the clinical information and evidence they need to improve outcomes of the organ transplant patient.

Infection Prevention and Control in Healthcare, Part I: Facility Planning, An Issue of Infectious Disease Clinics of North America, E-Book